Case report: Dysphonia associated with high-dose cytarabine therapy

Case report: Dysphonia associated with high-dose cytarabine therapy

Cytarabine is widely used in the treatment of hematological malignancies. Its common toxicities include myelosuppression and gastrointestinal disturbances. Additionally, it can cause central nervous system (CNS) symptoms, which include hoarseness, ataxic tremor, ataxic gait, nystagmus, dysmetria, an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ling Ma, Niya Huang, Haixi Zhang, Jia Liu, Zhiqing Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Pharmacology
Subjects:	acute myeloid leukemia dysphonia high-dose cytarabine adverse reaction case report
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1518298/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Retrospective review of dosing trends in botulinum toxin injections for the treatment of adductor spasmodic dysphonia in a long-term cohort
by: Gabrielle French, et al.
Published: (2020-01-01)

Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax
by: Claudio Fozza
Published: (2024-01-01)

A rare vascular manifestation in chronic myeloid leukemia: a case report and literature review of Bier's spot development during nilotinib treatment
by: Ahmed Alsaati, et al.
Published: (2025-01-01)

Modified CD15/CD16-CLL1 inhibitory CAR-T cells for mitigating granulocytopenia toxicities in the treatment of acute myeloid leukemia
by: Rui Zhang, et al.
Published: (2025-02-01)

Bioinformatics Interpretation of Exome Sequencing: Blood Cancer
by: Jiwoong Kim, et al.
Published: (2013-03-01)

Anuric Acute Kidney Injury in Chronic Myeloid Leukemia: A Rare Complication Case
by: Angela Kimberly Tjahjadi, et al.
Published: (2024-10-01)

Spontaneous splenic rupture in a teenager as first manifestation of acute myeloid leukemia: Case report and literature review
by: Antonio Villa, et al.
Published: (2018-11-01)

Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapies
by: Ugochi Ebinama, et al.
Published: (2025-01-01)

miR-182 promoter hypermethylation predicts the better outcome of AML patients treated with AZA + VEN in a real-world setting
by: Yilan Xu, et al.
Published: (2025-02-01)

Elucidation of the Molecular Interaction between miRNAs and the Gene, Involved in Acute Myeloid Leukemia, by the Assistance of Argonaute Protein through a Computational Approach
by: Rohit Pritam Das, et al.
Published: (2015-06-01)

A Nomogram Built on Clinical Factors and CT Attenuation Scores for Predicting Treatment Response of Acute Myeloid Leukemia Patients
by: Linna Liu, et al.
Published: (2025-01-01)

Characteristics and outcomes of patients with lymphoma who developed therapy-related acute myeloid leukemia or myelodysplastic syndrome – a retrospective analysis of the Polish Adult Leukemia Group
by: Aleksandra Gołos, et al.
Published: (2024-07-01)

A case report of acute promyelocytic leukemia with myeloid sarcoma of the lumbar spine and literature review
by: Yiwen Du, et al.
Published: (2025-01-01)

Rare skin adverse reactions induced by osimertinib: a case report and literature review
by: Ye Zhang, et al.
Published: (2025-01-01)

Increased Co-Expression of PD-L1 and CTLA-4 Predicts Poor Overall Survival in Patients with Acute Myeloid Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation
by: Chen C, et al.
Published: (2025-01-01)

Effects of Somatic Mutations Are Associated with SNP in the Progression of Individual Acute Myeloid Leukemia Patient: The Two-Hit Theory Explains Inherited Predisposition to Pathogenesis
by: Soyoung Park, et al.
Published: (2013-03-01)

Combination therapy of low-dose radiotherapy and immunotherapy in advanced metastatic nasopharyngeal carcinoma: a case report and literature review
by: Chun-Qiao Chen, et al.
Published: (2025-01-01)

Critically ill adult patients with acute leukemia: a systematic review and meta-analysis
by: Dara Chean, et al.
Published: (2025-01-01)

STAT signaling in the pathogenesis and therapy of acute myeloid leukemia and myelodysplastic syndromes
by: Zoe King, et al.
Published: (2025-03-01)

BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies
by: Mariam Markouli, et al.
Published: (2025-01-01)

Case report: A case report and literature review on the efficacy of high-dose aumolertinib combined intrathecal pemetrexed by Ommaya reservoir for EGFR-mutated NSCLC with leptomeningeal metastasis as the initial symptoms
by: Maoxi Zhong, et al.
Published: (2025-01-01)

CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
by: Lucas Touzet, et al.
Published: (2019-03-01)

Immune‐dysregulation harnessing in myeloid neoplasms
by: Mohammad Jafar Sharifi, et al.
Published: (2024-09-01)

Genetic Risk Prediction for Normal-Karyotype Acute Myeloid Leukemia Using Whole-Exome Sequencing
by: Seong Gu Heo, et al.
Published: (2013-03-01)

Valproic Acid Enhances Venetoclax Efficacy in Targeting Acute Myeloid Leukemia
by: Renshi Kawakatsu, et al.
Published: (2025-01-01)

Germline Single-Nucleotide Polymorphism <i>GFI1-36N</i> Causes Alterations in Mitochondrial Metabolism and Leads to Increased ROS-Mediated DNA Damage in a Murine Model of Human Acute Myeloid Leukemia
by: Jan Vorwerk, et al.
Published: (2025-01-01)

A novel perspective on survival prediction for AML patients: Integration of machine learning in SEER database applications
by: Zheng-yi Jia, et al.
Published: (2025-01-01)

A young adult patient with Philadelphia positive acute lymphoblastic leukemia presenting with extreme hyperleukocytosis
by: Gulten Tikit, et al.
Published: (2025-01-01)

Concentration-dependent effects of immunomodulatory cocktails on the generation of leukemia-derived dendritic cells, DCleu mediated T-cell activation and on-target/off-tumor toxicity
by: Hazal Aslan Rejeski, et al.
Published: (2025-01-01)

Update on glasdegib in acute myeloid leukemia – broadening horizons of Hedgehog pathway inhibitors
by: Fersing Cyril, et al.
Published: (2022-03-01)

The Comparison of Classical Statistical and Machine Learning Methods in Prediction of Thrombosis in Patients with Acute Myeloid Leukemia
by: Ilija Doknić, et al.
Published: (2025-01-01)

Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia
by: Elissa Tjahjono, et al.
Published: (2025-01-01)

T cell receptors specific for an imatinib-induced mutation in BCR-ABL for adoptive T cell therapy
by: Meng-Tung Hsu, et al.
Published: (2025-01-01)

Clinical efficacy and safety of first‐line nilotinib or imatinib therapy in patients with chronic myeloid leukemia—Nationwide real life data
by: Petra Belohlavkova, et al.
Published: (2024-09-01)

Screening potential antileukemia ingredients from sweet potato: integration of metabolomics analysis, network pharmacology, and experimental validation
by: Lianling Xu, et al.
Published: (2025-01-01)

Left Kidney Undifferentiated Spindle Cell Sarcoma with Myeloid Cell Leukemia-1 Amplification: Therapeutic Response to Bortezomib, Venetoclax, and Dexamethasone Therapy
by: Cheng-Yu Tang, et al.
Published: (2023-10-01)

Cellular heterogeneity and cytokine signatures in acute myeloid leukemia: A novel prognostic model
by: Jinxia Cao, et al.
Published: (2025-02-01)

Exogenous dihomo-γ-linolenic acid triggers ferroptosis via ACSL4-mediated lipid metabolic reprogramming in acute myeloid leukemia cells
by: Xiandong Jiang, et al.
Published: (2025-02-01)

Combined anti-leukemic effect of gilteritinib and GSK-J4 in FLT3-ITD+ acute myeloid leukemia
by: Qi Zhou, et al.
Published: (2025-02-01)

Case report: dysgeusia, strawberry tongue, and psoriatic eruptions after combination treatment with adalimumab, sulfasalazine, and etoricoxib for ankylosing spondylitis
by: Binglin Cui, et al.
Published: (2025-02-01)